Abstract
Pancreatic endocrine neoplasms (PanNENs) are epithelial tumors affecting adults between the ages of 40 and 60 [1]. They are usually solitary and sporadic but may be part of hereditary syndromes, including multiple endocrine neoplasia type 1 (MEN1), von Hippel Lindau (VHL), neurofibromatosis type 1 (NF1) and tuberous sclerosis complex (TSC).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Klimstra D, Arnold R, Capella C et al (2010) Neuroendocrine neoplasms of the pancreas. In:Bosman F, Carneiro F, Hruban R, et al (eds) World Health Organization classification of tumors of the digestive system. IARC, Lyon
O’Toole D, Salazar R, Falconi M et al (2006) Rare functioning pancreatic endocrine tumors. Neuroendocrinology 84:189–195
Kloppel G, Rindi G, Anlauf M et al (2007) Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 451 Suppl 1:S9-27
Jensen RT, Niederle B, Mitry E et al (2006) Gastrinoma (duodenal and pancreatic). Neuroendocrinology 84:173–182
de Herder WW, Niederle B, Scoazec JY et al (2006) Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 84:183–188
Anlauf M, Garbrecht N, Henopp T et al (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 12:5440–5446
Alexakis N, Neoptolemos JP (2008) Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 22:183–205
Hruban RU, Bishop Pitman M, Klimstra DL (2007) Endocrine Neoplasms, in Silverberg SG, Sobin LH (eds): Tumors of the pancreas. Washington, Armed Forces Institute of Pathology
Capelli P, Martignoni G, Pedica F et al (2009) Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med 133:350–364
Heitz PU, Komminoth P, Perren A et al (2004) Pancreatic endocrine tumours, in DeLellis RA, Lloyd RV, Heitz PU, et al (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. IARC Press, Lyon
Wiedenmann B, Franke WW, Kuhn C, et al (1986) Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A 83:3500–3504
Lloyd RV, Mervak T, Schmidt K et al (1984) Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol 8:607–14
Bishop AE, Polak JM, Facer P et al (1982) Neuron specific enolase: a common marker for the endocrine cells and innervation of the gut and pancreas. Gastroenterology 83:902–15
Rode J, Dhillon AP, Doran JF et al (1985) PGP 9.5, a new marker for human neuroendocrine tumours. Histopathology 9:147–158
Pelosi G, Bresaola E, Bogina G et al (1996) Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 27:1124–1134
Yachida S, Vakiani E, White CM et al (2012) Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 36:173–184
Rindi G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401
Scarpa A, Mantovani W, Capelli P et al (2010) Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 23:824–833
Fischer L, Kleeff J, Esposito I et al (2008) Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 95:627–635
Pape UF, Jann H, Muller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265
Barbarotto E, Schmittgen TD, Calin GA (2008): MicroRNAs and cancer: profile, profile, profile. Int J Cancer 122:969–977
Stumpf E, Aalto Y, Hoog A et al (2000) Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 29:83–87
Speel EJ, Richter J, Moch H et al (1999) Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 155:1787–1794
Hu W, Feng Z, Modica I et al (2010) Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway. Genes Cancer 1:360–368
Nagano Y, Kim do H, Zhang L et al (2007) Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis. Endocr Relat Cancer 14:483–492
Rigaud G, Missiaglia E, Moore PS et al (2001) High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 61:285–292
Missiaglia E, Moore PS, Williamson J et al (2002) Sex chromosome anomalies in pancreatic endocrine tumors. Int J Cancer 98:532–538
Arnold CN, Sosnowski A, Schmitt-Graff A et al (2007) Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. Int J Cancer 120:2157–2164
House MG, Herman JG, Guo MZ et al (2003) Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg 238:423–431; discussion 431-432
Malpeli G, Amato E, Dandrea M et al (2011) Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors. BMC Cancer 11:351
Corbo V, Beghelli S, Bersani S et al (2012) Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries. Ann Oncol 23:127–134
Jiao Y, Shi C, Edil BH et al (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331:1199–1203
Moore PS, Missiaglia E, Antonello D et al (2001) Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 32:177–181
Corbo V, Dalai I, Scardoni M et al (2010) MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Endocr Relat Cancer 17:771–783
Heaphy CM, de Wilde RF, Jiao Y et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425
Missiaglia E, Dalai I, Barbi S et al (2010) Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 28:245–255
Roldo C, Missiaglia E, Hagan JP et al (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677–4684
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Italia
About this chapter
Cite this chapter
Scarpa, A., Corbo, V. (2013). Pathology and Genetics. In: Pederzoli, P., Bassi, C. (eds) Uncommon Pancreatic Neoplasms. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2673-5_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-2673-5_8
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2672-8
Online ISBN: 978-88-470-2673-5
eBook Packages: MedicineMedicine (R0)